Over the past several years, there has been a lot of hype about glycation and advanced glycation end-products, or AGEs, as they’ve become known to the skincare world. Yet, with all the focus on glycation, much of this condition still remains a mystery to patients and scientists alike.
Part of the mystery stems from the lack of evidence tying specific aging reactions to glycation. With so many...
Articles
Over the past several years, there has been a lot of hype about glycation and advanced...
Written content has become crucial to the success of a medical aesthetic practice....
Itsy bitsy teeny-weeny bikinis are the standard uniform among the svelte set in...
Dermatologist and dermatologic surgeon Anna D. Guanche, MD, entered medical school...
Products
SkinCeuticals Advanced Pigment Corrector clears and brightens skin by...
The Lutronic INFINI fractional radiofrequency-based system has received FDA...
Edge Systems HydraFacial Daily Essentials help patients maintain the results...
The InMode Aesthetic Platform from InMode Aesthetic Solutions allows...
Allergan (www.allergan.com) has added Aline HA, a solid-state, hyaluronic acid dermal filler thread, to its aesthetic product portfolio.
The cross-linked HA thread, which resembles fishing line, is injected with a needle. It was developed by Geoffrey Gurtner, MD, professor of plastic surgery at the Stanford School of Medicine, as an alternative to liquid dermal fillers for facial wrinkles, particularly hard-to-treat forehead lines.
Aline Aesthetics, a subsidiary of the TauTona Group, a medical device incubator and investment fund, announced the sale. “We are delighted to announce the sale of our third product, Aline HA, to Allergan,” said Dr. Gurtner MD, who is also managing partner at TauTona.
Skincare manufacturer SkinCeuticals is launching the SkinCeuticals Advanced Clinical Spa with Manhattan Dermatology and Cosmetic Surgery. Located in midtown Manhattan, the spa's treatment menu will feature SkinCeuticals homecare and professional products.
"We believe a personalized integrated skincare plan is the most efficacious way to achieve long-lasting skincare results," said Snehal P. Amin, MD, co-founder and director of Manhattan Dermatology and Cosmetic Surgery (MDCS). "We are not only focused on clinical results and efficacy, but also focused on providing patients with a premium experience. SkinCeuticals' focus on Integrated Skincare—the blend of clinical procedures with in-office professional treatments and advanced homecare—is perfectly aligned with what we at MDCS are already practicing and advising our patients to do."
"As a brand, it is exciting to finally bring the full SkinCeuticals experience to life in one comprehensive, premium flagship location,” said Brenda Wu, U.S. General Manager of SkinCeuticals.
Mary Spellman, MD, FAAD, is the new Chief Medical Officer of Convoy Therapeutics, a biopharmaceutical company focused on unmet needs in the medical dermatology and aesthetics markets. Dr. Spellman has previously served as CMO of Revance Therapeutics and held senior positions at Biogen Idec and Novartis.
"Mary brings a wealth of experience in clinical development to Convoy, and we are proud to have her as a member of our executive management team as we enter the next exciting phase in the company's growth,” said John Muraski, PhD, CEO of Convoy. “Mary will be instrumental in overseeing all of our planned clinical studies for CycloPsorb and our other programs."
Dr. Spellman will work alongside Convoy's executive management team, all of whom bring decades of experience in the pharmaceutical and biotechnology industries, including John Muraski, PhD (CEO), David Loynd (CFO), Deborah Slee, PhD (VP of Research & Development), Ann Deren-Lewis, MBA (VP of Sales & Marketing), and Shep Bentley, RAC (VP of Regulatory Affairs).
CycloPsorb is a topical formulation of cyclosporine for psoriasis and eczema. The company is also the developer and Khalay HA, a topical hyaluronic acid filler for the rapid treatment of...
